TSHR and geroderma osteodysplastica: To determine whether the specific binding of YC3 to TSHR can be used as a molecular probe for clinical application, orbital adipose tissues from GO patients and healthy donors were incubated with Cy3‐labeled YC3 and FITC‐labeled TSHR antibodies.